Regulating Axonal Responses to Injury: The Intersection between Signaling Pathways Involved in Axon Myelination and The Inhibition of Axon Regeneration by Sudheendra N. R. Rao & Damien D. Pearse
REVIEW
published: 08 June 2016
doi: 10.3389/fnmol.2016.00033
Regulating Axonal Responses to
Injury: The Intersection between
Signaling Pathways Involved in Axon
Myelination and The Inhibition of
Axon Regeneration
Sudheendra N. R. Rao 1* and Damien D. Pearse 1,2,3,4,5
1 The Miami Project to Cure Paralysis, University of Miami Miller School of Medicine, Miami, FL, USA, 2 The Department
of Neurological Surgery, University of Miami Miller School of Medicine, Miami, FL, USA, 3 The Neuroscience Program,
University of Miami Miller School of Medicine, Miami, FL, USA, 4 The Interdisciplinary Stem Cell Institute, University of Miami
Miller School of Medicine, Miami, FL, USA, 5 Bruce W. Carter Department of Veterans Affairs Medical Center, Miami, FL, USA
Edited by:
Sari Hannila,
University of Manitoba, Canada
Reviewed by:
Åsa Fex-Svenningsen,
University of Southern Denmark,
Denmark
Soheila Karimi-Abdolrezaee,
Univeristy of Manitoba, Canada
*Correspondence:
Sudheendra N. R. Rao
sudhee26@miami.edu
Received: 23 March 2016
Accepted: 02 May 2016
Published: 08 June 2016
Citation:
Rao SNR and Pearse DD (2016)
Regulating Axonal Responses to
Injury: The Intersection between
Signaling Pathways Involved in Axon
Myelination and The Inhibition
of Axon Regeneration.
Front. Mol. Neurosci. 9:33.
doi: 10.3389/fnmol.2016.00033
Following spinal cord injury (SCI), a multitude of intrinsic and extrinsic factors adversely
affect the gene programs that govern the expression of regeneration-associated genes
(RAGs) and the production of a diversity of extracellular matrix molecules (ECM).
Insufficient RAG expression in the injured neuron and the presence of inhibitory ECM
at the lesion, leads to structural alterations in the axon that perturb the growth
machinery, or form an extraneous barrier to axonal regeneration, respectively. Here,
the role of myelin, both intact and debris, in antagonizing axon regeneration has
been the focus of numerous investigations. These studies have employed antagonizing
antibodies and knockout animals to examine how the growth cone of the re-growing
axon responds to the presence of myelin and myelin-associated inhibitors (MAIs)
within the lesion environment and caudal spinal cord. However, less attention has
been placed on how the myelination of the axon after SCI, whether by endogenous
glia or exogenously implanted glia, may alter axon regeneration. Here, we examine
the intersection between intracellular signaling pathways in neurons and glia that
are involved in axon myelination and axon growth, to provide greater insight into
how interrogating this complex network of molecular interactions may lead to new
therapeutics targeting SCI.
Keywords: myelination, axon regeneration, spinal cord injuries, Schwann cell, oligodendrocytes, signaling
pathways, radial growth, adaptive myelination
MYELINATING GLIA OF THE CNS AND PNS
Neuron-glia interactions have been fundamental to the structure and function of the brain
throughout evolution (Herculano-Houzel, 2014). Oligodendrocytes (OLs) in the central nervous
system (CNS) and Schwann cells (SCs) in the peripheral nervous system (PNS) ensheathe
axons with myelin for the promotion of saltatory conduction (Nave and Werner, 2014). In the
case of OLs, they extend their processes spirally inward, around the axons, in a corkscrew-like
manner to lay down a multi-lamellar, compact, lipid rich sheath (myelin sheath; myelin from
myelós, Greek for marrow) on the axons. Formation of the myelin sheath occurs in an outside
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to inside fashion by a process involving homotypic fusion of
myelinophore organelles within the confines of their processes
(Ioannidou et al., 2012; Snaidero et al., 2014; Szuchet et al., 2015).
OLs represent almost 75% of the neocortical glial population,
and each OL is capable of laying down myelin on 40–60 short
axonal segments of multiple CNS axons with varying diameter
(Matthews and Duncan, 1971; Lubetzki et al., 1993; Shaham,
2006; Pelvig et al., 2008; Fields et al., 2015). In the CNS,
the renewal of myelinating OLs comes from oligodendrocyte
precursor cells (OPCs). OPCs, activated by specific mitogens
[e.g., platelet derived growth factor (PDGF) and neurotrophin-3
(NT3)], and differentiating factors [e.g., thyroid hormone T3,
insulin growth factor-1 (IGF-1), transforming growth factor-β1
(TGF-β1) and stromal derived factor-1 (SDF-1)] proliferate
and progress through a pre-myelinating phase to eventually
become myelinating OLs (Boulanger and Messier, 2014). CNS
myelination begins prenatally and proceeds gradually at the level
of axonal tracts in a rostral to caudal—dorsal to ventral gradient
(Schreyer and Jones, 1982; Almeida et al., 2011; Wang and
Young, 2014). In mice, the generation of a surprisingly large
numbers of OLs occurs even in adulthood, which contribute
towards a distinct remodeling of the myelin sheath and
remyelination after CNS injury (Powers et al., 2013; Young et al.,
2013). Studies have also suggested that, in humans, neocortical
myelination is protracted, lending support to the idea that the
presence ofmyelination and remyelination in the adult is relevant
across species (Miller et al., 2012; Glasser et al., 2014; Shafee et al.,
2015). Accumulating evidence suggests that not only do actively
growing axons become myelinated, but also axons which have
reached their target can undergo continual myelin remodeling,
a capability that persists when the axon is injured (Yeung et al.,
2014).
In the PNS, SCs are derived from neural crest cells that pass
through precursor and immature stages to eventually become
myelinating or non-myelinating SCs (Jessen and Mirsky, 2005).
In rodents, Schwann cell precursors (SCPs) are observed in
spinal nerves by E12-E14 (Jessen et al., 1994; Dong et al.,
1999). Survival of SCPs usually requires growth factors like
PDGF, NT-3, endothelin, fibroblast growth factor (FGF) and
IGF (Woodhoo et al., 2004). SCPs continue to proliferate under
mitogens such as axonal neuregulin 1 (NRG1) and TGFβ to
become immature SCs that envelop a large group of axons
en masse (Ridley et al., 1989; Morrissey et al., 1995; Woodhoo
and Sommer, 2008). Axonal caliber and glia-axonal contact
are critical in deciding the myelinating and non-myelinating,
inter-convertible fates of SCs (Weinberg and Spencer, 1975;
Aguayo et al., 1976; Trapp et al., 1988; Voyvodic, 1989;
LeBlanc and Poduslo, 1990). Through the process of radial
sorting, that continues postnatally, immature SCs differentiate
and establish a 1:1 relationship with peripheral axons and
spirally ensheathe and myelinate large diameter axons, whereas
some mature SCs, termed Remak cells, remain associated with
multiple, small diameter axons without myelinating them (Feltri
et al., 2015).
Myelination is a multistage process with considerable
overlap among its different phases. In general, these phases
involve: (1) the migration and ensuing differentiation of
glial precursors into mature myelinating glia; (2) the initial
recognition of the axon, axon-glia contact, axonal segment
selection and subsequent ensheathment of the target axonal
segments by the myelinating glia; (3) the initiation of myelin-
associated protein expression in the myelinating glia and
finally; (4) the compaction and maturation of the myelin
sheath (Szuchet et al., 2015). Further fine-tuning of the
myelination process involves the generation of functional
axonal domains such as nodes of Ranvier, paranodes and
juxtaparanodes.
There is a striking difference, however, in the structural
proteins that make up the myelin of the CNS and the
PNS. CNS myelin produced by OLs is compact, rich in
glycolipid (e.g., galactocerebroside) and sulfolipid-sulfatide,
has a higher concentration of proteolipid protein (PLP)
and consists of unique glycoproteins, such as the myelin-
associated inhibitors (MAIs) including myelin oligodendrocyte
glycoprotein (OMgP/MOG; Nave and Trapp, 2008; Jahn et al.,
2009). In contrast, myelin protein zero (P0/MPZ) and peripheral
myelin protein (PMP22) constitute characteristic structural
proteins of peripheral myelin (Patzig et al., 2011). Despite
these structural and composition differences, axonal signaling
plays an important role in the regulation of both OL and SC
development, myelin biogenesis and their ability to myelinate
CNS and the PNS axons, respectively (Barres and Raff, 1999;
Nave and Trapp, 2008; Taveggia et al., 2010). In humans,
OPC maturation takes place almost 3 months before the onset
of myelination (around 40 weeks), reiterating the need for
specialized signaling mechanisms between OLs and axons for
the initiation of myelination (Brody et al., 1987; Kinney et al.,
1988; Back et al., 2002). In contrast, SCPs and immature SCs
appear at around 12 weeks of fetal development, and mature
SCs commence peripheral myelination 2 weeks later, first at
the motor roots, then the sensory roots (Cravioto, 1965).
Most of the peripheral myelination completes within 1 year of
birth, whereas CNS myelination continues well past the first
decade of life (Jakovcevski et al., 2009; Bercury and Macklin,
2015).
Injury to CNS axons, in contrast to that of PNS axons,
leads to impaired axonal regeneration as a result of the actions
of various intrinsic and extrinsic factors (Afshari et al., 2009).
These factors adversely affect the gene programs that govern
the expression of regeneration-associated genes (RAGs) and
the production of a diversity of extracellular matrix molecules
(ECMs), leading to structural alterations in the axon that
perturb the axonal growth machinery or lead to the formation
of extraneous barriers to axonal regeneration at the site of
lesion (Kaplan et al., 2015). Here, the role of myelin (both
intact and debris) in altering injured axon growth responses
has been the focus of both targeted therapeutic approaches
and transgenic mouse studies, in which components of myelin,
specifically MAIs, have been blocked, or are genetically knocked
out (Raisman, 2004; Schwab and Tuszynski, 2010; Lee and
Zheng, 2012). However, there has been less attention on how
myelination of the injured axon, whether by endogenous or
exogenously transplanted glia as a therapeutic approach, may
alter axon regeneration. Combinatorial approaches involving
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the modulation of the: (1) properties of glial scar; and
(2) MAI signaling and transplantation of myelination-competent
cells, with or without trophic factors, have all yielded
limited axonal regeneration caudal to the injury site in
various spinal cord injury (SCI) models (Deumens et al.,
2005). Understanding the pathways involved in myelination
and how these pathways may directly play a role in or
intersect with, signaling cascades involved in axon growth
or its inhibition, may provide new avenues for developing
regenerative therapies after CNS injury. The current review
examines the distinct signaling pathways implicated in axon-
glia communication duringmyelination, and discusses how these
same pathways play a role in altering axonal growth responses
after injury.




Notch (notch1 and notch2) is a transmembrane receptor and
Delta, Delta-like (Dll-1, 3, 4), Serrate/Jagged (jagged 1, jagged 2),
F3/Contactin and NB3 (Contactin-6) are its known ligands
(Andersson et al., 2011). Notch ligands that are present on
axons play an instructive role in the development of various glia,
including OLs (Gaiano and Fishell, 2002; Givogri et al., 2002;
Stump et al., 2002), and regulate the differentiation of SCPs
and the proliferation of SCs, but postnatally can also act in an
inhibitory fashion towards SC mediated myelination (Woodhoo
et al., 2009). Axons harbor extracellular notch ligands jagged1,
F3/contactin and NB3 near the paranodes, whereas OLs and SCs
express the notch receptors 1 and 2 (Stidworthy et al., 2004;
Woodhoo et al., 2009). Adult rodent and human brain shows
expression of notch receptors (notch1, notch2) and its ligand
(jagged 1; Berezovska et al., 1998; Stump et al., 2002; Chen
et al., 2005). Axonal jagged1 blocks OPC differentiation into
OLs within the adult rodent brain (Grandbarbe et al., 2003;
Park and Appel, 2003). However, evidence also suggests that
notch signaling can enhance myelination in a ligand-dependent
manner (Hu et al., 2003).
Notch signaling (Figure 1) begins with trans-binding of
the ligands to notch receptors. This event leads to proteolytic
cleavage of the notch extracellular truncated domain, first
by a disintegrin and metalloprotease (ADAM), and then by
γ-secretase, which releases the notch intracellular domain
(NICD) to permit its translocation to the nucleus (Andersson
et al., 2011). In the nucleus, in conjunction with the
RBPJ/MAML (recombining binding protein suppressor of
hairless/ mastermind-like) transcription activation complex,
NICD acts to de-repress notch target genes such asHes/Hesr/Dec
(hairy/enhancer; hairy/enhancer related; differentiated embryo
chondrocyte 1; Andersson et al., 2011).
Hu et al. (2003) proposed a switch model in which axonal
jagged-1 expression initially blocks OPC differentiation in aHes1
dependent manner. Then, as jagged1 expression decreases with
development, the interaction of F3/contactin with notch1, notch2
or NB3 with notch1, could then promote nuclear translocation of
NICD, and the transcription of myelin-associated genes, myelin-
associated glycoprotein (MAG) and CNPase, in a RBPJ/Hes1
independent manner (Wang et al., 1998; Hu et al., 2003; Popko,
2003; Cui et al., 2004). This non-canonical notch activation was
found to be exclusively dependent on F3/Contactin/NB3, and
was mediated by Deltex1 (DTX1), an E3 ligase also known to
antagonize c-Jun N-terminal kinase (JNK), and promote the
degradation of NICD, as well as MAPK/ERK kinase kinase 1
(MEKK1; Liu and Lai, 2005; Zhang P. et al., 2010). However,
given the role of DTX1/p300 in functioning as a non-canonical
downstream transcriptional regulator of notch, the exact
mechanism of transcriptional activation of myelin-associated
genes by DTX1 remains to be elucidated (Yamamoto N. et al.,
2001). It is plausible that parallel activation of other axon-
glia signaling might post-translationally influence the activity
and interactions of DTX1, and direct it towards promyelination
signaling. In an apotransferin-induced-cortical remyelination
model, notch activation correlated with F3/Contactin expression
(Aparicio et al., 2013). Increasing expression of F3/contactin and
NB3 during the early postnatal period has been documented
in the rat spinal cord (Cui et al., 2004). This apparent change
of ligands for the same receptor (notch1) promotes maturation
of OLs on demand from axons (Givogri et al., 2002; Hu et al.,
2003). In such a scenario, if axons continue to maintain a high
expression of jagged1, they can potentially tip the balance of
myelination signals towards its inhibition.
Among the 30 members of the ADAM family of proteolytic
enzymes, ADAM10 and ADAM17 play an important role in
myelination within the PNS (van Tetering et al., 2009; La Marca
et al., 2011; Palazuelos et al., 2014). ADAM10 cleaves notch1
in a ligand-dependent manner, whereas cleavage of notch by
ADAM17 is ligand-independent (Bozkulak and Weinmaster,
2009). In addition, cytoplasmic notch activity is known to be
negatively regulated by numb (Puca and Brou, 2014). The exact
mechanism of numb-mediated negative regulation of notch
signaling is not known, but multiple mechanisms are proposed,
including its interference with NICD endocytosis, NICD nuclear
translocation, and notch/RBPJ/MAML-mediated transcription
of genes (Giebel and Wodarz, 2012; Flores et al., 2014).
Notch1 is also required for the timely differentiation
of neuronal progenitors, and cells that are deficient in
notch1 undergo premature neurogenesis, but die by apoptosis
before completing the terminal differentiation into post-mitotic
neurons (Lutolf et al., 2002). Expression of notch1 in 6 DIV
(day in vitro) mouse E16–18 cortical neurons, and neurite
forming NB2A cells, inhibits neurite extension (Berezovska
et al., 1999; Franklin et al., 1999). Notch signaling was also
demonstrated to inhibit axonal regeneration in C.elegans after
axotomy, and preventing notch activation post-injury resulted
in enhanced regeneration (El Bejjani and Hammarlund, 2012).
Further, numb was shown to reverse notch-mediated axon
growth inhibition in 6 DIV cultures of E16–18 mouse cortical
neurons, highlighting the importance of negatively regulating
notch signaling to promote neuritogenesis (Berezovska et al.,
1999; Puca and Brou, 2014). In mice, subsequent to compressive
SCI, the expression of numb was observed to be predominantly
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FIGURE 1 | The involvement of Notch in the regulation of myelination and axonal growth. Myelinating glia (A) and the axonal membrane (B) both harbor
notch ligands (C) and notch receptors (D). Proteases (e.g., ADAM10 and γ-secretase) activate the canonical notch signaling pathway (E) by processing the ligand
bound notch receptor to release notch intracellular domain (NICD) (F). The protease ADAM 17 can activate canonical notch signaling in a ligand independent manner
(G). NICD undergoes translocation to the nucleus and binds to a transcriptional de-repression complex containing RBPJ/MAML transcription factors (H1,H2). In
myelinating glia, canonical notch signaling activates a cascade of downstream genes (e.g., Hes1), halting OPC differentiation (H1). Whereas, in neurons, canonical
notch signaling upregulates DUSP1 and DUSP6 in a Hes/Hesr/Dec dependent manner (H2). DUSP1 and DUSP6 inhibit axonal growth and neuritogenesis by
negatively regulating the p38 MAPK and ERK1/2 pathways, respectively (I). Novel notch ligands (e.g., F3/contactin or NB3) activate non-canonical notch signaling (J)
that recruits the NICD/Deltex1 (DTX1)/p300 transcription complex, thus activating genes that are essential for myelination. The notch antagonist, numb, inhibits
various steps in both the canonical and non-canonical notch signaling pathway (K), whereas DTX1 plays a critical regulatory role in both non-canonical notch
signaling and the c-Jun N-terminal kinase (JNK) signaling pathway (L).
upregulated in both NeuN-positive neurons and GFAP-
positive astrocytes, in rostral as well as caudal spinal cord,
for up to 10 mm from the lesion (Chen et al., 2005;
Wilhelmsson et al., 2012). However, following injury to the
nervous system, output of the notch signaling pathway with
the effects of this increased expression of numb remains
unknown.
In a mouse SCI compression model, notch1 expression
significantly increased both at the mRNA and protein level
(Yamamoto S. et al., 2001; Chen et al., 2005). In contrast to
numb, notch1 mRNA expression was identified for up to 10 mm
rostral and caudal to the injury, exclusively within neurons
(Chen et al., 2005). Notch1 mRNA expression was detected
beginning 2 days post injury and was still apparent at 14 days
post injury (Chen et al., 2005). Notch-mediated inhibition of
axonal regeneration appears to be ligand-independent, a finding
that could potentially explain the absence of an improvement
in hind limb motor function when the jagged1 antagonist
(Jagged1-Fc-Chimera) was administered intravenously in mice
immediately following a 50 kdyn thoracic T10 contusion
SCI (Fassbender et al., 2011; El Bejjani and Hammarlund,
2012). Interestingly, inactivation of γ-secretase using its
inhibitor, DAPT (N-[N-(3,5-difluorophenacetyl)-L-alanyl]-
S-phenylglycine-t-butyl ester), was sufficient to overcome
notch-mediated axonal growth inhibition in C.elegans following
LASER-assisted axotomy (El Bejjani and Hammarlund, 2012).
However, DAPT, which eventually decreases the available NICD
pool, was ineffective when applied 2 h after LASER-assisted
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axotomy, suggesting an alteration in the post-injury molecular
milieu, that could provide resistance to notch modulation
through putative transcriptional events and post-translational
modifications.
The signaling cascade involved in axon growth inhibition
via notch activation needs further elucidation (Figure 1). In a
RBPJ dependent manner, notch signaling has been shown to lead
to the dephosphorylation of ERK1/2, and the inhibition of the
Ras/Raf/MKK1/2/ERK1/2 pathway through the upregulation of
MAPK phosphatase (Lip-1/MKP-3/DUSP6), and the antagonism
of p38 MAPK by the up-regulation of MKP-1 (DUSP1; Muda
et al., 1996; Berset et al., 2001; Kondoh et al., 2007). Notch
signaling can regulate p38 MAPK/JNK by positively regulating
the mTOR pathway in a c-myc dependent manner to increase
the expression of MKP1 (DUSP1) via Akt (Protein Kinase B;
PKB) signaling (Chan et al., 2007; Rastogi et al., 2013). The role
of the p38 MAPK pathway and the downstream effector of the
JNK pathway, c-jun, are now being recognized as the critical
molecules required for resetting SC fate towards a reparative
phenotype (Arthur-Farraj et al., 2012; Yang et al., 2012). The
p38 MAPK and JNK pathways are also specifically important
in axonal regeneration (Nix et al., 2011). However, work in
C.elegans has demonstrated that notch can negatively influence
axonal regeneration without affecting the DLK-1/MEK4–7/JNK
pathway (El Bejjani and Hammarlund, 2012). Reports have
also suggested that there are cross talks between NICD and
the canonical β-catenin pathway, as well as NF-κB, HIF1,
and TGFβ-BMP signaling pathways (Andersson et al., 2011;
Bonini et al., 2011). Hence, notch mediated down regulation of
axonal growth could primarily be due to its negative regulation
of the p38 MAPK and ERK pathways, and its effects on
myelination could be due to a complex modulation of the
transcriptional network involved with myelin-associated gene
expression and its indirect modulation of Akt signaling (Flores
et al., 2008).
Conversely, multiple reports have highlighted that there is
post-translational regulation of NICD by MAPK/ERK, which
influences the transcriptional output of canonical notch signaling
(Stockhausen et al., 2005; Tremblay et al., 2013; Yamashita et al.,
2013). In addition, the MAPK signaling pathway shares multiple
substrates with the cyclic AMP/PKA cascade and in turn can
be regulated by cyclic AMP in a PKA-dependent (PKA/RhoA
or PKA/PTP) or PKA-independent (Epac/Rap1 or Epac/Rit)
manner (Gerits et al., 2008). Anecdotal reports of cyclic AMP
being able to upregulate jagged 1 levels in osteoblasts, in a PKA-
dependent manner, supports the potential existence of a wider
notch regulatory network in neural cells (Weber et al., 2006).
Examining the cross talk between notch signaling and cyclic
AMP after injury, under conditions where levels of cyclic AMP
are dramatically reduced (Pearse et al., 2004; Hannila and Filbin,
2008; Lau et al., 2013), may reveal novel players at the intersection
of those signaling pathways.
In summary, notch signaling (Figure 1) constitutes an
emerging component of axon-glia communication during
injury. Notch interaction with its ligands plays an important
role in modulating myelination, and warrants further work
to better define these relationships, and to identify the
intermediaries involved in these processes. In particular, nodes
involving the interaction of notch with MAPK signaling
(e.g., DUSPs) and cytoskeletal network may offer unique
therapeutic targets for enhancing remyelination repair and
axonal regeneration.
Neuregulin-ErbB Signaling
NRG1 is a member of the neuronal growth and differentiation
factor family best known to be critical for SC development
(Birchmeier and Nave, 2008). NRG1, the most studied of
the four neuregulin genes, produces at least 15 different
isoforms from multiple transcription start sites and alternative
splicing (Nave and Trapp, 2008). All the six main isoforms
of NRG1: type I (Heregulin: HRG; soluble), II (glial growth
factor: GGF), III [sensory motor neuron-derived factor (SMDF);
transmembrane], IV, V and VI have a similar epidermal growth
factor (EGF)-like domain but distinct N-terminal regions.
Expression of NRG1 has been detected in the uninjured spinal
cord, as well as following SCI, in neurons, axons and OLs
(Vartanian et al., 1999; Gauthier et al., 2013). NRG1 binds to
membrane spanning receptor tyrosine kinases (RTKs), ErbB3
and ErbB4, which are part of the EGF receptor superfamily
(Iwakura and Nawa, 2013). CNS expression of ErbB3, and
to some extent that of ErbB4, is observed exclusively in
OLs (Sussman et al., 2005; Makinodan et al., 2012). ErbB
receptor subunit expression is present in the adult brain,
spinal cord as well as dorsal root ganglia (DRGs; Bermingham-
McDonogh et al., 1996; Martínez et al., 2004; Pearson and
Carroll, 2004). In the PNS, SCs predominantly express ErbB2
and ErbB3 (Garratt et al., 2000). Binding of NRG1 to
ErbB3 or ErbB4 leads to the activation of multiple signaling
pathways (Figure 2), ensuing heterodimerization with ErbB2,
since ErbB3, which contains a pseudokinase domain, cannot
activate downstream effectors (Weiss et al., 1997; Maurel and
Salzer, 2000; Burgess et al., 2003). Proteolytic cleavage of
the NRG1 N-terminal domain by ADAM17 or β-secretase,
is a prerequisite for NRG1/ErbB2/3 signaling (Ronchi et al.,
2015).
Much of our understanding regarding the role of NRG1 in the
process of myelination comes from experiments with knockout
mice (Brinkmann et al., 2008; Newbern and Birchmeier, 2010).
Conditional knockout of NRG1 in cortical projection neurons,
before the onset of cortical myelination, did not lead to any
changes in the myelin assembly of the subcortical white matter
or spinal cord, whereas parallel observations within CNS-
PNS border zones suggested that SC development and its
myelination program were altered (Dragatsis and Zeitlin, 2000;
Michailov et al., 2004; Brinkmann et al., 2008). In nestin-cre
driven NRG1 knockout mice, changes in the CNS were again
largely unremarkable, though animals did exhibit early lethality
(Brinkmann et al., 2008). However, in spinal cord explants
obtained from the NRG1 knockout mice, a selective and severe
reduction in OL development was observed that could be rescued
with recombinant NRG1 (Vartanian et al., 1999). Conversely,
when NRG1 type I or type III were overexpressed under a Thy1.2
driver in mice, hypermyelination was seen in thin (0.4 µm)
neocortical fibers, without an overt change in OL numbers
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FIGURE 2 | NRG/Erb signaling in the control of peripheral myelination and axonal growth. BACE1 processed axonal NRG1-type III interacts with ErbB
receptors (A), and promotes cell survival, proliferation and myelination by activating various signaling pathways, including mTOR via PI3K/Akt (B) and ERK1/2 via
Ras/Raf (C). However, NRG1 type III cleavage by ADAM17 conveys inhibitory signals to the myelination program (D). In Schwann cells (SCs), axonal NRG type III
(transmembrane) represses NRG type I (soluble) isoform expression via ERK1/2 (E). Rapid axonal NRG1 release can be spatially regulated by neurotrophic factors
[e.g., Nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), and glial cell-derived neurotrophic factor (GDNF)], that are released by SCs, and act via
TrkA, TrkB or GFRα1/RET receptors, respectively, on axonal surfaces (F). Neurotrophins induce the coordinated efforts of PKCδ and cell surface proteases such as
BACE1 and ADAM, which cleave a precursor form of axonal NRG1 to release its active soluble form (G). In addition, neurotrophins also activate the Shc/PI3K/Akt
survival pathway and Shc/Ras/ERK1/2 differentiation pathways. Activation of ERK by neurotrophins can inhibit PDE4 (phosphodiesterase) activity, which leads to the
antagonism of cyclic AMP hydrolysis (H). Elevating intracellular cyclic AMP is critical to overcoming axon growth inhibition by myelin-associated molecules, such as
myelin-associated glycoprotein (MAG), which is present in non-compact myelin. NRG1/ErbB signaling is further regulated by the adaptor protein Erbin and ErbB2
spatial localization determinant protein, LINGO-1, a component of the MAI-Nogo receptor-signaling complex (I). Cyclic AMP can sustain NRG1 type I-mediated
transient Akt phosphorylation via PKA dependent phosphorylation of the ErbB receptor, a mechanism that involves Rap1b-PP2A signaling (J). NRG1/ErbB signaling
is dispensable for the myelination program in the CNS, and a detailed understanding of the NRG1/ErbB interaction network following the CNS injury is lacking.
(Brinkmann et al., 2008). In the same study, NRG1 type III
overexpression lead to premature myelination in the mouse optic
nerve (Brinkmann et al., 2008). Closer examination of the OLs
in the optic nerve of these mice showed that they exhibited an
increase in soma size and a widened territory of coverage by their
processes, suggesting that NRG1 overexpression could produce
subtle changes in OL morphology (Brinkmann et al., 2008). OLs
have been shown to respond in culture to soluble NRG1 by
producing galactocerebroside and myelin basic protein (MBP;
Vartanian et al., 1997, 1999; Fernandez et al., 2000; Calaora
et al., 2001). Thus, discrepancies between in vivo and cell culture
observations with OLs in NRG1 knockout animals highlight
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some limitations of the models used, though they do suggest that
NRG1 may play a role in OL function and myelination at later
stages, but it is largely dispensable for myelination during CNS
development.
On the contrary, loss of ErbB2 produces a severe reduction
in OL numbers, as well as an impairment in their axon
ensheathing capability (Park et al., 2001). The development
of a transgenic mouse in which a dominant negative ErbB2
was expressed specifically in OLs, through use of a MBP
promoter, showed that competitive antagonism of ErbB2
resulted in widespread hypomyelination and defects in OL
differentiation (Kim et al., 2003). Similarly, the prevention of
ErbB2 translocation to lipid rafts by LINGO-1, a component
of the MAI-Nogo receptor-signaling complex, prevents OL
differentiation (Lee et al., 2014). In the PNS, effective NRG1-
ErbB myelination signaling needs Erbin expression in SCs, a
leucine rich repeat (LRR) and PDZ domain-containing adapter
protein belonging to the LAP family that interacts with ErbB2
(Borg et al., 2000; Tao et al., 2009). Erbin also appears to be
an essential component for peripheral axon remyelination after
injury (Liang et al., 2012). Interfering with Erbin expression
inhibits NRG1 mediated Akt activation (Tao et al., 2009). These
findings collectively suggest an important role of ErbB2, not
only in the maturation of myelinating glia during development,
but also for their functioning in repair when the nervous
system is injured. In the CNS, ErbB3 knockout, in contrast,
has no effect on OL differentiation and myelination (Schmucker
et al., 2003). OLs from mice with an OL specific knockout of
ErbB3 and ErbB4 were still observed to myelinate the CNS
in a timely manner as compared to their wild type controls
(Brinkmann et al., 2008). On the contrary, activation of ErbB3
leads to OL proliferation and differentiation, whereas ErbB4
activation leads to the suppression of OL maturation (Sussman
et al., 2005; Makinodan et al., 2012). Further studies with the
selective targeting of ErbB receptors during injury remain to be
undertaken.
Neurotrophic factors secreted by SCs can spatially regulate
rapid axonal NRG1 release (Esper and Loeb, 2004). Nerve
growth factor (NGF), brain-derived neurotrophic factor (BDNF)
and glial cell-derived neurotrophic factor (GDNF) released by
SCs act via TrkA, TrkB or GFRα1/RET receptors respectively,
on axonal surfaces. These neurotrophins provide trophic
support to underlying axons and drive NRG1/ErbB signaling
in SCs within the vicinity of axons, as well as regulate
their myelination ability (Hoke et al., 2003; Ascano et al.,
2009; Esper and Loeb, 2009). Neurotrophins induce the
coordinated actions of PKCδ and cell surface proteases such
as BACE1 and ADAM, which cleave a precursor form of
axonal NRG1 to release its active soluble form (Loeb et al.,
1998; Esper and Loeb, 2009). In addition to activating PKC
via the PLCγ pathway, neurotrophins activate the Shc/PI3K/Akt
survival and Shc/Ras/ERK1/2 differentiation pathways (Ohira
and Hayashi, 2009). Activation of ERK by neurotrophins
can inhibit PDE4 (phosphodiesterase 4) activity, which leads
to the antagonism of cyclic AMP hydrolysis (Figure 2).
Elevating intracellular cyclic AMP is critical to overcoming
axon growth inhibition by myelin-associated molecules, such
as MAG, which are present in non-compact myelin (Gao
et al., 2003; Patzig et al., 2011). NGF differentially regulates
myelination in the CNS and the PNS, inhibiting myelination
by OLs, while promoting myelination by SCs (Chan et al.,
2004). Though work remains to improve our understanding
of the modulation NRG1/ErbB signaling by neurotrophins
in OLs, this signaling interaction has important implications
for transplantation experiments after SCI that involve the
use of genetically modified SCs with the overexpression of
neurotrophins.
Axonal NRG1 interacts with ErbB2/3 to activate
various signaling pathways (Figure 2; Ras/ERK1/2, NF-
κB, Ras/PI3K/Akt, Shc/Ras/PI3K, Shc/Shp2/Src/FAK and
PLCγ/Calcineurin) that promote cell survival, proliferation
andmyelination (Newbern and Birchmeier, 2010; Heermann and
Schwab, 2013). PI3K/Akt signaling downstream of NRG1/ErbB
can serve as an additional mechanism to promote myelination,
even at later stages of the development (Flores et al., 2008;
Goebbels et al., 2010). Cyclic AMP, when used as a mitogen
in SC cultures, can sustain NRG1 type I (heregulin)-mediated
Akt phosphorylation via PKA dependent phosphorylation of
the ErbB receptor, a mechanism that involves Rap1b-PP2A
signaling (Monje et al., 2006; Hong et al., 2008). Conversely,
constitutively active Akt (possibly acting through mTOR)
can enhance myelination in the CNS without affecting OL
numbers, but does not seem to have any role in the PNS
myelination (Flores et al., 2008; Narayanan et al., 2009). The
NRG1/ErbB signaling pathway also has an extensive cross talk
(covered below) with other signaling pathways originating
from notch, neuronal merlin, β integrins and GPR126/cyclic
AMP adhesion G protein (Pietri et al., 2004; Woodhoo et al.,
2009; Mogha et al., 2013; Schulz et al., 2014; Petersen et al.,
2015). Recently, a nuclear variant of ErbB3 has been identified,
which is under transcriptional control of NRG1; siRNA
knockdown of nuclear-ErbB3 in SC-neuron co-cultures lead
to a nearly 50% reduction in myelin segments, prompting a
re-evaluation of the role of ErbB3 in myelination (Adilakshmi
et al., 2011).
The current understanding of the involvement of NRG in
peripheral regeneration following injury is that the axonal NRG
type III (transmembrane) represses NRG type I (soluble) isoform
expression in SCs via ERK1/2 (Stassart et al., 2013). After the
injury, the autocrine/paracrine NRG1 signals originating from
SCs take over to promote de-differentiation and myelination by
denervated SCs (Raphael et al., 2011; Stassart et al., 2013; Mei
and Nave, 2014). However, studies in peripheral nerve injury also
provide evidence that following injury, axonal NRG1, though not
essential, is required for remyelination in a rate limiting fashion
(Fricker et al., 2009, 2011, 2013).
Following injury, in the PNS, NRG1/ErbB isoforms show
a differential expression pattern during the degeneration and
regeneration phases (Ronchi et al., 2015). Intriguingly, NRG1
type III (b/c) is upregulated in the regeneration phase of
peripheral nerve injury via a reversible switch between ADAM17
to BACE1 dependent cleavage (Ronchi et al., 2015). ADAM17, a
ligand-independent activator of notch signaling, has previously
been shown to produce NRG1 type III cleavage that is inhibitory
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to SC myelination (Bozkulak and Weinmaster, 2009; La Marca
et al., 2011). BACE1, on the other hand, is known to produce
a promyelinating cleavage product of NRG1 type III, but this
product was recently deemed non-essential for the peripheral
myelination program (Willem et al., 2006; Velanac et al., 2012).
These studies highlight the dichotomy and dynamic nature
of decision making between myelination and axon growth
programs in the PNS. Whether similar mechanisms operate
following injury to the CNS is currently unknown. Following
injury, ErbB2 protein levels are upregulated by 3rd day and
persist for 4 weeks, whereas ErbB3 expression is upregulated at
around 7 days and persists until 4 weeks (Ronchi et al., 2015).
Intriguingly, the protein level of ErbB2 does not reflect the
pattern of mRNA expression, which is downregulated after PNS
injury. This can be related to a relative resistance of ErbB2 to
degradation by several debated mechanisms that include efficient
recycling, regulation of its endocytosis and HSP90/Cdc37
induced stabilization, or post-transcriptional regulation by the
ERK/PDE/cAMP/PKA network (Bertelsen and Stang, 2014).
Together, these studies suggest that NRG/ErbB signaling could
be regulated in a complex manner, especially after injury, and
more work needs to be done to iron out the discrepancies that
exists among various studies.
Within 1 day following moderate thoracic contusion SCI in
mice with the OSU device, NRG1 type I expression increases
at the lesion site, which after 2 weeks, returns to control
levels (Lasiene, 2009). Conversely, the expression of NRG1
type III was found to remain significantly decreased at all time
points following the injury (Lasiene, 2009). In the same study,
intrathecal infusion of NRG1 type III but not NRG1type I-β1
(Ser2-Lys246) into the mouse spinal cord lead to a transient
increase in myelin sheath thickness in the axons caudal to
the injury site (Lasiene, 2009). On the contrary, a study
using a compressive thoracic SCI model in rats observed a
downregulation of NRG1 type I expression following injury,
along with no change in ErbB2/3/4 receptor expression (Gauthier
et al., 2013). In a similar SCI model (compression) sustained
intrathecal infusion of NRG1 type I-β1 (Thr176-Lys246) to the
spinal cord was able to increase the expression of CNPase (a
marker of OLs) and NF200 (axonal neurofilament), which was
reversed by an ErbB2/4 inhibitor (Gauthier et al., 2013). In
addition, a study administering subcutaneous NRG1 (soluble
Type II; GGF2; Nrg1-β3) 24 h after thoracic contusion SCI in
rats (weight drop, 10g/2.5 cm height) and mice (60 kdyn, T9),
for a delivery period of 7 days, showed an increase in adult OL
number and a subsequent increase in the myelination of spared
axons (Whittaker et al., 2012). These findings highlight the
differential characteristics of NRG1 isoforms. In extrapolating
the usefulness of different NRG1 isoforms for therapeutic
purposes, it is important therefore that NRG1 domains and
amino acid stretches are adequately identified, in addition to the
SCI model system used for a research study (Cheriyan et al.,
2014). It is likely that some amino acid stretches on NRG1
domains might interact with pathways countering OL survival
and myelination programs. A detailed evaluation of this research
direction remains to be undertaken.
Studies to date suggest that the requirement of NRG1 in
vivo is different for the PNS and the CNS. In the PNS,
NRG1 is essential for SC differentiation and myelination,
however, for the CNS, even though NRG1 is capable of
altering the myelination process, it is dispensable (Brinkmann
et al., 2008). However, after the injury there is considerable
evidence that NRG1/ErbB signaling might play an important
role in re-myelination and the survival of glia in both the CNS
and the PNS (Lasiene, 2009; Whittaker et al., 2012; Gauthier
et al., 2013). Even though there is anecdotal in vitro evidence
that NRG1-β1 can promote neurite outgrowth, a majority of
studies report that NRG1 promotes neuronal survival and acts
as a neuroprotectant in adult injured tissues (Bermingham-
McDonogh et al., 1996; Zhang et al., 2004; Edwards and
Bottenstein, 2006; Iaci et al., 2010; Li et al., 2012; Whittaker
et al., 2012). Accumulating evidence suggests that different
isoforms of NRG1 may hold the key to understanding their
precise role in CNSmyelination and axon regeneration following
injury. Specifically, there is a need to revisit the role of NRG1
isoforms, and the signaling cascade emanating from lipid-
raft-inserted ErbB2 for its role in modulating the myelination
program. Emerging understanding of NRG1/ErbB signaling
necessitates further experiments to determine its broader clinical
significance.
β-Secretase and Metalloprotease Signaling
Neuronally expressed β-site amyloid precursor protein (APP)
cleaving enzyme1 (BACE1), a transmembrane protein and an
asparatyl protease that is upregulated during PNS myelination,
is another player in NRG1/ErbB signaling (Willem et al., 2006).
BACE1, as well as ADAM10 and 17, can cleave NRG1 (type
I and type III) at their C-termini to their EGF domains,
whereas BACE1 and ADAM17 can also cleave NRG1 type III
at its N-terminus to its EGF domain, releasing them from the
neuronal membrane and assisting in their paracrine signaling
(Montero et al., 2000; Syed and Kim, 2010; Luo et al., 2011;
Fleck et al., 2013). NRG1 N-terminal cleavage releases α-sEGF
and β-sEGF by ADAM17 and BACE1 respectively, whereas
C-terminal cleavage by ADAM or BACE1 releases α/β-CTF,
which undergoes rapid turnover (Fleck et al., 2013). Both
α/β-sEGF can activate ErbB3 phosphorylation and promote
downstream Akt signaling (Fleck et al., 2013). Crude N-terminal
fragment of NRG1 (NTF) activates Akt in a similar fashion (Luo
et al., 2011). However, BACE1-mediated processing of NRG1was
found to be crucial for myelination in SC-DRG co-culture studies
(Luo et al., 2011). BACE1 released β-sEGF was sufficient to
rescue peripheral hypomyelination in BACE1 mutant zebrafish
(Fleck et al., 2013). Recently, for the first time, a study observed
NRG1 cleavage to switch between two enzymes (ADAM17 to
BACE1 and back to ADAM17) over the course of regeneration,
after rat sciatic nerve crush as well as in a neurotmesis repair
paradigm (Ronchi et al., 2015).
BACE1 knockout mice show a specific defect in myelination
and not in axonal ensheathment. This is exemplified by the
decreased expression of MBP and PLP proteins, enriched
in OL-laid compact myelin, and normal expression levels of
MAG, a protein enriched in the periaxonal membrane, in
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BACE1 knockout mice (Hu X. et al., 2006). Expectedly, in
BACE1 knockout mice, full length NRG1 was increased and a
reduced activation of PI3K-Akt was noted (Hu X. et al., 2006).
However, a re-evaluation of the BACE1 knockout showed more
specific defects in remyelination following cuprizone induced
demyelination (Treiber et al., 2012). CNS hypomyelination in
BACE1 knockout mice was observed previously in hippocampal
and optic nerves, while work by Treiber et al. (2012), in the
corpus callosum, suggested region specific differences in the
myelination program in the brain, as observed in other studies
(Tomassy et al., 2014). Recently, breeding BACE1 knockout
mice to mice expressing a constitutively active Akt (Akt-
DD), specifically in OLs, showed rescue of BACE1-induced
CNS hypomyelination by Akt, reinforcing that NRG1-ErbB/Akt
signaling is downstream of BACE1 (Hu et al., 2013). In the PNS,
BACE1 was present on both axons and SCs, and identified as
important for the proper myelination of axons (Fleck et al., 2012;
Hu et al., 2015).
Understanding the substrates of BACE1 during different
phases of regeneration can provide unique insights into the PNS
regeneration program. Studies have indeed applied quantitative
proteomics to identify the substrates of BACE1 in cell models and
zebrafish (Hemming et al., 2009; Hogl et al., 2013). At least 24
unique proteins accumulate in the membrane fractions of brain
from BACE1 knockout zebrafish, suggesting them to be putative
substrates (Hogl et al., 2013). Many of the molecules are involved
in axonal growth, guidance and sprouting such as NCAM, L1,
Plexin A3 and Glypican1 (Jakeman et al., 2006; Zhang et al.,
2008; Bai and Pfaff, 2011; Shen, 2014). These findings stress the
need for further work to understand the importance of BACE1
specific substrates in clinically related injury models of the PNS
and CNS.
Fibroblast Growth Factor-2 (FGF2)
Signaling
FGF2 isoforms have been known to be differentially regulated in
the DRG and sciatic nerve (Meisinger and Grothe, 1997). DRG
neurons express both FGFR1 and FGFR2 (Grothe and Nikkhah,
2001; Hausott et al., 2011). OPCs and differentiated OLs
express FGF receptors in a developmentally-regulated manner.
OPCs express FGFR1 and FGFR3, and differentiated OLs
express FGFR1. On the other hand, paranodal myelin shows
clusters of FGFR2 on lipid rafts of OLs (Bansal, 2002; Bryant
et al., 2009). Downstream signaling for FGFR1/2 seems to
occur via Raf-MEK-ERK1/2 and PI3K/Akt/mTOR pathways,
but it is plausible that FGF1/2 signals are also transmitted by
other receptors (β1 integrins), and affected via other various
intracellular signaling pathways (Grothe and Nikkhah, 2001;
Hausott et al., 2011; Ornitz and Itoh, 2015).
Various FGF isoforms exert differential effects on OLs
and OPCs. Specifically, FGF-2 promotes proliferation and
inhibits differentiation of OPCs in vitro, but promotes process
elongation, cell cycle re-entry, and decreases MBP protein
expression in mature OLs (Fortin et al., 2005). Even though
FGF2 signaling for OPC proliferation in vivo and ex vivo seems
to be dispensable, a decrease in MOG, MBP transcription, and
thickness of the myelin sheath have been observed after the
long term absence of both FGFR1/2 in OLs (Furusho et al.,
2012). On the contrary, administration of FGF2 to SCs in culture
decreases the expression of P0 mRNA as well as its protein. In
addition, FGF2 was able to inhibit the positive regulation of the
myelin sheath component protein P0 via Forskolin, an activator
of adenylyl cyclase (Morgan et al., 1994). These studies highlight
the differential effect of FGF signaling in CNS and PNS glia,
and point towards co-regulators that could be driving such a
differential response.
Intrathecal injection of bFGF (30 min to 1 h post spinal
contusion injury, infusion for 7 days), has been shown to
produce positive effects on tissue preservation (Lee et al.,
1999; Rabchevsky et al., 1999). Recently, acute subcutaneous
administration (within 30 min of injury, then every 2 days
post SCI) of human FGF2 was carried out in a rat spinal
cord hemisection injury model showing decreased gliosis and
a concurrent decrease in chondroitin sulfate proteoglycans
(CSPGs; Goldshmit et al., 2014). Additionally, increased
neuronal progenitor and radial glial numbers, as well as a
change in the morphology of the glial scar and glial cell
morphology (bipolar), towards that are supportive for axonal
regeneration, were observed with FGF2 (Goldshmit et al.,
2014). Combinatory treatment of a spinal thoracic transection
injury in rats with a SC-fibrin bridge, along with recombinant
human FGF2, produced a 3–4 fold increase in surviving
NeuN positive cells in the adjacent host cord as compared
to control (Meijs et al., 2004). However, recombinant human
FGF2 failed to produce any significant growth of axons into
the bridge, and did not lead to improved functional recovery
(Meijs et al., 2004). By overexpressing the different isoforms
of FGF2 in SCs and using them in a sciatic nerve graft,
Haastert et al. (2006) demonstrated that FGF2–21/23 kDa (High
Molecule Weight FGF2; HMW-FGF2) isoform preferentially
promoted myelination whereas FGF2–18 kDa (Light Molecule
Weight FGF2; LMW-FGF2) isoform was observed to be
inhibitory to the myelination of regenerated axons (Haastert
et al., 2006). In addition, the studies suggested that LMW
and HMW FGF2 differentially regulated sensory and motor
neuron regeneration and functional recovery (Haastert et al.,
2006; Allodi et al., 2013). Other studies have shown that SCs
overexpressing FGF2 enhance peripheral nerve regeneration
(Danielsen et al., 1988; Fujimoto et al., 1997; Timmer et al.,
2003). It is plausible, however, that FGF2 has pleotropic effects
on myelination and axonal regeneration. Studies in FGF2
knockout mice support this view; where following sciatic nerve
crush injury, distal to the crush site, at least 5× the number
of regenerating axons were present as compared to control.
This improvement is seen along with increased myelination
and axon diameter, as well as enhanced sensory recovery,
which the authors ascribed to an enhanced myelin clearance
(Jungnickel et al., 2004, 2010).
In summary, these findings support that there exists a
differential, isoform specific role of FGF2 in axon regeneration.
Further experiments are required to understand the role of FGF2
isoforms and the modulation of FGFR endocytosis in relation to
axonal regeneration and myelination following SCI (Goldshmit
et al., 2012; Adeeb and Mortazavi, 2014).
Frontiers in Molecular Neuroscience | www.frontiersin.org 9 June 2016 | Volume 9 | Article 33
Rao and Pearse Signaling Pathways in Axons after Injury
Insulin Growth Factor (IGF) Signaling
IGF-I and II are polypeptides that play an important role in the
development and maturation of neurons and glia, particularly
projection neurons and cerebellar neurons (Andersson et al.,
1988; Liu et al., 2000). Neurons secrete IGF-1 during activity
via somatodendritic exocytosis in a syaptotagmin-10 dependent
manner (Cao et al., 2011). IGF works through IGF receptor 1 and
2 (IGF1R, IGF2R), which are expressed on OLs. IGF receptor
(IGF1R) abundance decreases with age (Garofalo and Rosen,
1989). IGF-1 signaling seems to be crucial for OPC survival,
proliferation, and differentiation as well as CNS myelination
(D’Ercole et al., 2002). Similarly in the PNS, IGF-1 promotes
survival, proliferation and differentiation of SCs by inducing
myelin-associated P0 protein expression (Cheng et al., 1996;
Stewart et al., 1996; Cheng and Feldman, 1997; Sondell et al.,
1997). In OL-specific IGF-1 knockout mice (Olig1-cre and
PLP-cre driver), a severe reduction in CC1+ mature OLs as
well as NG2+ OLs was observed, along with a decrease in the
myelin-associated protein PLP (Zeger et al., 2007). In global
IGF-1 knockout mice, cortex, hippocampus and diencephalon
show the maximum effect of decreased myelination, whereas
brainstem and cerebellum show modest demyelination (Ye et al.,
2002). However, post-demyelination, a local increase of IGF1
mRNA levels in the spinal cord failed to produce any OL-
mediated myelination (O’Leary et al., 2002). The relevance of
IGF-1 signaling with respect to myelination of long axonal tracts
in the spinal cord and long relay neurons has yet to be established
(Lee et al., 1992; Bibollet-Bahena and Almazan, 2009; De Paula
et al., 2014). These findings highlight the need to search for
co-modulators of CNS IGF signaling. Interestingly, SCs express
IGF-1 and IGF-II, and are the most abundant source of IGF-1
supply in extra-ocular muscles (Kerkhoff et al., 1994; Feng and
Von Bartheld, 2010). However, besides IGF1 expression, SCs
also express IGF-binding proteins such as IGFBP4 and 5, which
modulate IGF1 action. IGFBP4 was shown to inhibit IGF1
action, whereas IGFBP5 works along with IGF1 to promote
myelination (Clemmons, 1998; Hammarberg et al., 1998; Cheng
et al., 1999a,b).
IGF-1 specifically enhances axonal growth of pyramidal,
brainstem and spinal motor neurons (Dobrowolny et al.,
2005; Ozdinler and Macklis, 2006). On the contrary, IGF-1 is
ineffective for the axonal growth of callosal projection neurons
and retinal ganglion neurons (Goldberg et al., 2002; Catapano
et al., 2004). Similarly, transplantation of IGF-1 secreting bone
marrow stromal cell grafts into a dorsal column hemisection
lesion in the rat, led the regeneration of raphespinal and
cerulospinal, but not corticospinal axons (Hollis et al., 2009).
Together these findings suggest that additional molecules could
regulate the downstream response of IGF1 in a cell-specific
manner. Recently, the β subunit of IGF1R was observed to be
expressed on the distal axons of adult retinal ganglion cells, and
negative modulation of IGF1R expression/activity led to nearly
20-fold decrease in axonal regeneration potential of the RGC
neurons in culture (Dupraz et al., 2013). Similarly, following
transection of the ventral funiculus in the rat lumbar spinal cord,
the expression of both IGF-1 and IGFBPs (2, 5 and 6) were
found to be upregulated in the ventral and ventrolateral gray
matter as well as in the scar tissue (Hammarberg et al., 1998). The
combination of the IGF-1 secreting cell graft with the infusion of
an IGFBP inhibitory non-peptide ligand (NBI-317712) improved
the survival of corticospinal neurons after an internal capsule
injury in rats (Hollis et al., 2009). These findings reiterate that
further understanding of the downstream bottlenecks of IGF1
signaling could provide novel tools for therapeutic intervention.
Downstream signaling from IGF-1 occurs via the
Ras/Raf/MEK/ERK and PI3K/Akt/mTOR pathways. Recently,
ubiquitin ligases MDM4/2, along with the transcription factor
p53, were observed to form an inhibitory complex that blocked
IGF1R signaling (Joshi et al., 2015). Nutilin3, an anticancer drug
in development that blocks MDM2-p53 inhibitory interactions,
has been shown to enhance axon regeneration in a IGF1R
dependent manner (Joshi et al., 2015). Suppressing p53 levels
or p53 activity also enhances the reprogramming efficiency of
fibroblasts to convert into dopaminergic neurons (Liu et al.,
2014; Rasmussen et al., 2014). Together, these findings suggests
that in long projection neurons, IGF signalingmight be amenable
to transcriptional modulation, and calls for further exploration
of the mechanisms that increase the expression of IGF1R,
decrease the expression of inhibitory IGFBP (thus preventing
sequestration of useful IGF) or that enhance IGF1R-mediated
signaling.
Integrin Signaling
Integrins belong to a family of cell surface receptors that
recognize ECM proteins such as fibronectin, laminin, collagen,
vitreonectin, and which can also bind to other integrin family
members (DeSimone et al., 1987; Hynes, 1987). The α and β
subunits of integrins come in various forms, and binding of a
combined αβ integrin to the ECM promotes a positive feedback
loop between integrin clustering, intracellular cytoskeleton
assembly and ECMorganization (Giancotti and Ruoslahti, 1999).
OLs have been observed to express various combinations of αβ
integrins, including α6β1 (Milner et al., 1997). The expression
levels of integrins change throughout OPC development and
during the generation of mature OLs. In addition, axons
themselves considerably affect integrin subunit expression on
OLs (Milner and Ffrench-Constant, 1994; Milner et al., 1997).
The ligand for α6β1 integrin, laminin2α, is known to be expressed
on retinal projections, dendritic spines, and differentially on
myelinating axons of the brainstem and proximal spinal cord
(Morissette and Carbonetto, 1995; Tian et al., 1997; Colognato
et al., 2002). Laminin is also abundant on the SC basal lamina
(Bunge et al., 1986).
Binding of ligand to the β-integrin receptor leads to
auto-phosphorylation of focal adhesion kinase (FAK). The
FAK/Paxillin complex then recruits the SRC family of protein
kinases (Fyn, Src, Lyn and especially Lck) to transfer the signal
to CRK/p130Cas, which in turn recruits the small GTPase Rac1
to activate NF-κB or JNK pathways (Chen et al., 2000; Schaller,
2001; Iwahara et al., 2004; Ness et al., 2013). In the PNS, Rac1
activated integrin signaling in SCs is crucial for radial sorting
and subsequent myelination of PNS axons (Nodari et al., 2007).
Binding of ligands to β-integrin can also directly activate the
PI3K/Akt survival pathway via FAK.
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In a mouse model, the overexpression of dominant negative
β1 integrin (dnβ1) reduced FAK activation (p-Tyr397) by 43% in
optic nerves as compared to controls, but not in the spinal cord,
suggesting a region-specific involvement of integrin signaling
(Camara et al., 2009). In addition, an increase in the minimum
axon diameter required to initiate myelination was noted in the
optic nerves of the dnβ1 mice. This is very similar to NRG
levels influencing the myelination program (covered below).
FAK knockout mice showed similar findings (Forrest et al.,
2009). Selective knockout of FAK in OLs, using a PLP-cre
driver led to a reduction in the number of myelinated fibers
in P14 mouse optic nerves (Forrest et al., 2009). However, at
P28, both wild type and mutant dnβ1 and FAK knockout mice,
show a comparable number of myelinated axons in the optic
nerves, suggesting a transient and region-specific FAK influence.
Contrary to the transient nature of themyelination defect in dnβ1
integrin mice, α6 integrin knockout mice show hypomyelination
due to the apoptotic cell death of OLs (Colognato et al.,
2002). Interestingly, OL apoptosis was rescued by NRG1β1
(neuregulin), and OPCs from the α6 integrin knockout mouse,
when differentiated on laminin2α (α6β1 integrin ligand) coated
plates in the presence of NRG1β1, were able to myelinate
appropriately (Colognato et al., 2002). NRG1β1-induced survival
and differentiation in the presence of the laminin2α depends on
the MAPK signaling pathway, with subsequent phosphorylation
(Ser112)-mediated inhibition of Bad, a pro-apoptotic molecule, in
a PI3K-independent manner (Fang et al., 1999; Colognato et al.,
2002). These findings suggested that NRG1β1 was able to switch
the dependence of the integrin response from PI3K to MAPK.
β1 integrins interact with the extracellular domain (L1-Fc)
of F3/Contactin, a protein enriched on axons that activates
Fyn kinase by repressing its inhibitory phosphorylation of
Fyn-pTyr531 (Laursen et al., 2009). Supporting this finding, OL-
specific knockout of contactin-1, using a PLP-cre driver, led to
a 46% decrease in OL processes and impaired myelin membrane
expansion (Colakoglu et al., 2014). Taken together, these findings
implicate an integrated role of integrin-FAK pathway in deciding
the onset and delay of myelination, and a cross talk with
other molecular pathways could potentially influence its region
specificity.
Laminin/β1 integrin signaling assists neuritogenesis by
mediating microtubule assembly as well as stabilization
in axons (Lei et al., 2012). Recent studies suggest that
the integrin ligand, laminin, does this by switching
α3β1/α7β1 integrin-mediated F-actin dynamics/exocytic
signaling from the Ena/VASP/WAVE/VAMP2 pathway to
FAK/SRC/Cdc42/Rac/Arp2/3/VAMP7 complex-dependent
signaling (Krause et al., 2003; Gupton and Gertler, 2010;
Havrylenko et al., 2015). Loss of β1 integrin leads to decreased
pLKB1 (Ser431) and SAD-A/B kinase levels, and alters
microtubule stabilization via the FAK/SAD pathway (Lei
et al., 2012). The mechanistic aspects of LKB1 phosphorylation
are elusive. However, PKA might phosphorylate LKB1, since
α4β1 and α5β1 integrins are known to function as AKAPs (PKA
specific A-Kinase anchoring proteins), and Ser431 in LKB1 is a
PKA consensus phosphorylation site (Lim et al., 2008; Lei et al.,
2012). These findings suggest that integrin-associated Src kinases
can integrate signals from axons as well as the basal lamina and
interact with a larger network of partners intracellularly.
MAIs further regulate these cell-specific integrin pathways.
MAG stimulates asymmetric clathrin and calcium-mediated
endocytosis of β1 integrins at the growth cone, and MAG likely
performs a similar function elsewhere in axons (Hines et al.,
2010). Since MAG is usually present at the axon-glial junction, it
is plausible that the dynamic regulation of the surface expression
ofMAG couples integrin signaling with the myelination program
at the axon-glial junction.
In summary, integrin signaling has a profound influence
on both myelination and axon regeneration. Axons and glia
have been demonstrated to mutually activate and modulate the
integrin signaling pathway (Eva et al., 2012; Eva and Fawcett,
2014).
Cell Adhesion Molecules (CAMs)
CAMs upon the plasma membrane are critical to neuron-
glia interactions, bringing neuronal (in this case axonal) and
oligodendrocyte membranes together. CAMs either activate
signaling pathways themselves or help juxtapose signaling
complexes (Pollerberg et al., 2013). In addition, CAMs play an
important role in the patterning of axonal functional domains
(e.g., node of Ranvier, paranode, juxtaparanodes) with the
involvement of adjacent glia (Normand and Rasband, 2015).
There are at least four groups of CAMs described, which differ
largely in their functional requirement for calcium. Of these,
classic cadherins are calcium-dependent cell-to-CAMs that work
in tandem with catenins (α, β and p120), their cytoplasmic
binding partners, which connect them to the actin cytoskeleton
(Takeichi, 2007).
In the nervous system, OLs, SCs and axons express the
prototype molecule, N-cadherin, in an age-dependent manner.
When N-cadherin function was blocked by a peptide, only
50% of Purkinje cell axons were myelinated in an organotypic
cerebellar slice culture model, suggesting its important role in
myelination (Schnadelbach et al., 2001). The cytoplasmic domain
of cadherin can sequester β-catenin, thus modulating the levels of
available β-catenin for the canonical Wnt signaling pathway, as
well as β-catenin’s association with APC (adenomatous polyposis
coli), a molecule implicated in the stabilization of microtubules
(Hansen et al., 2008). Studies suggest that the Wnt signaling
pathway could be an essential pro-myelination cascade (Tawk
et al., 2011). Association of the cadherin cytoplasmic domain
with α/β catenin and p120 is positively regulated by GSK3β
and CaMKII, while it is negatively regulated by Src, Fer, abl
and EGFR kinases (Nelson, 2008). Following cervical spinal
cord unilateral hemisection, activation of the Wnt signaling
pathway in corticospinal axons antagonizes regeneration via the
Wnt1/Wnt5a/Ryk signaling complex (Liu et al., 2008; Lewallen
et al., 2011; Tawk et al., 2011). The cytoplasmic cadherin
domain also regulates both RhoGTPase activity, by interacting
with p120, and actin dynamics, by interacting with α catenin
(Cavallaro and Dejana, 2011). Conversely, Rho GTPase regulates
the clustering of cadherins on the cell surface (Fukata and
Kaibuchi, 2001; Grosheva et al., 2001). Cadherins can also bind to
several growth factor receptors, including FGFR, and modulate
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their intracellular signaling, either by activating them in a
ligand-independentmechanism, or by recruiting components for
signaling units, which include adaptor proteins (Shc), kinases
(Src, CSK) and phosphatases (SHP2, RPTPβ/η; Cavallaro and
Dejana, 2011).
Nectins are the second group of calcium-independent CAMs
that interact with themselves on the same cell (homophilical)
or with nectin present on another cell (heterophilic; Takai
et al., 2003). Further, a third group, nectin-like molecules
(Necl), specific to nervous tissue, resemble nectins in structure
and function and are expressed on axons (Kakunaga et al.,
2005). Necl-1 has a strict neuronal expression in the cortex,
retina, cerebellum and spinal cord (Kakunaga et al., 2005; Park
et al., 2008). Necl-1 regulates time dependent critical aspects of
myelination (Park et al., 2008; Zhu et al., 2013). Necl-1 knockout
mice showed delayed axonal myelination of both the optic tract
and spinal cord, which normalizes by 60 days post-birth (Park
et al., 2008). Given a complex network of interactions and
ligands, discerning the exact roles of CAMs inmyelination would
be an elaborate engagement, and has been excellently reviewed by
Pollerberg et al. (2013).
The IgSF (immunoglobulin superfamily) is the fourth group
of CAMs that do not depend on calcium and are present on
axons. Growing axons express at least nine types of IgSF CAMs
(NCAM1/2, L1-CAM, Contactin1/2, NRCAM, ALCAM, CHL1,
and Neurofascin; Pollerberg et al., 2013). The IgSF members
have a complex interaction network; they not only interact
with themselves, but also with other CAMs in a homotypical
or heterotypical manner. Extracellularly, IgSF CAMs have
been noted to interact with CSPGs (neurocan, phosphacan),
ECM components (Tenascin C and R, MMP14), β1 integrins,
growth receptors (GDNF/GFRα1, FGF-R, TrkB), semaphorin
receptors (Neuropilin 1, Plexin A1), ephrin receptors (Eph A
3/4/7), sodium and potassium channels (SCN1B, Kir 3.3), and
with some unusual interacting partners, such as prion protein
(PrPC), APP and extracellular GAPDH (Pollerberg et al., 2013).
Intracellularly, IgSF CAMs routinely interact with cytoskeletal
components such as ankyrin and the microtubule-associated
protein, doublecortin (DCX; Rader et al., 1996; Kizhatil et al.,
2002).
NCAM, one of the prominent members of IgSF CAM,
is known to be involved in neural differentiation, axonal
guidance and branching (Walsh and Doherty, 1997). Expression
of unmodified NCAM persists during myelination (Bartsch
et al., 1989). In contrast, post-translational modification of
NCAM by the addition of sialic acid (PSA-NCAM) has
been reported to negatively regulate myelination, with axons
undergoing myelination only when they do not express
PSA-NCAM, suggesting that inhibitory signals strongly regulate
the myelination program (Charles et al., 2000; Fewou et al.,
2007; Jakovcevski et al., 2007). The role of NCAM in
myelination and neuroprotection could be more complex given
its unconventional partners. For example, NCAM is known
to interact with FGF and GDNF (GFRα1) receptors. Thus a
trans-interaction with similar glial receptors can activate growth
and differentiation pathways, driving differential myelination via
FGF2 signaling (Jacobsen et al., 2008). Following transection
SCI in rodents, NCAM levels increase in the dorsal spinal
cord, motor neurons and corticospinal tract fibers (Tzeng et al.,
2001). Investigations of contusive SCI in NCAM knockout
mice revealed extensive neuronal apoptosis, decreased 5HT
axon regeneration, and defective ERK and GAP43 signaling
when compared to wild-type controls (Zhang S. et al., 2010).
However, how NCAM, both native and surface modified, can
alter ERK/GAP43 signaling and be neuroprotective in the injury
scenario is unclear.
L1-CAM, a member of the IgSF CAM family, is intricately
involved in axon growth and guidance during development
(Cohen et al., 1998; Kenwrick and Doherty, 1998). Strong
expression of L1-CAM has been found on unmyelinated
optic nerve axons that are not in contact with glial cells,
whereas it was absent from axon-glial contact regions (Bartsch
et al., 1989). Trans-interactions of axonal L1-CAM can activate
integrin signaling on glia, regulating axon-glia interactions
and myelination (Silletti et al., 2000; Guseva et al., 2011).
Transplantation of genetically engineered SCs producing L1, or
secreting its chimeric form, L1-Fc, into the SCI lesion in mice,
led to enhanced serotonergic fiber sprouting into, and across,
the lesion (Lavdas et al., 2010). In addition, in transgenic mice
that overexpressed L1 in neurons, severe contusion SCI studies
suggested that L1-CAM could enhance catecholaminergic fiber
regeneration and sprouting (Jakovcevski et al., 2013). It has been
found that MBP, a myelin-associated protease present in both
CNS and PNSmyelin, is capable of cleaving L1-CAM to promote
neuritogenesis (Lutz et al., 2015). This suggests that, similar to β1
integrins, myelin-associated proteins also can modulate CAM-
mediated interactions.
Neurons express contactin, another member of the IgSF CAM
family, which interacts heterophilically with L1-CAM, NRCAM
and neurofascin (Falk et al., 2002). Since contactins do not
have an intracellular domain, their signaling requires additional
recruited molecules (Rios et al., 2000; Charles et al., 2002; Traka
et al., 2002, 2003; Gautam et al., 2014). Contactin functions as a
non-canonical notch ligand, and likely has numerous cell surface
interaction partners (Hu Q. D. et al., 2006). Contactin2, another
member of contactin superfamily, present on both SCs and OLs
at the juxtaparanodal region, was recently discovered to be a
BACE1 substrate, and an interaction partner of neuronal Caspr2
(a contactin-neurofascin interaction modulator) at paranodal
areas (Rios et al., 2000).
Axons and glia harbor a host of molecules (including
gliomedin, NrCAM and various isoforms of neurofascin), which
take part in thematuration of the nodes of Ranvier onmyelinated
axons (Thaxton and Bhat, 2009). Myocilin, a Wnt and ErbB2/3
signaling regulator, interacts with gliomedin, NrCAM, and
neurofascin (NF186; Kwon et al., 2013). Knocking out myocilin
upregulates DLG1-PTEN in sciatic nerves (Cotter et al., 2010;
Kwon et al., 2013). The DLG1-PTEN interaction negatively
regulates peripheral myelin thickness, likely by stabilizing PTEN
and decreasing Akt activation (Cotter et al., 2010). DLG1-
mediated negative regulation of myelination was found to be
transient, whereas a fine-tuning of PI3K-Akt-mediated mTOR
signaling by another protein, DDIT4 (DNA damage-inducible
transcript 4 protein), was found to lead to a sustained negative
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regulation of peripheral myelin thickness (Noseda et al., 2013).
Conversely, the interactions of glial NrCAM and axonal
contactin, as well as of glial neurofascin and axonal NrCAM
have been shown promote neurite outgrowth in cultured tectal
neurons (Morales et al., 1993; Grumet, 1997).
In summary, CAMs have dual roles in myelination and axonal
growth that, at present, remain underinvestigated, particularly
following injury. CAMs communicate withmultiple downstream
signaling pathways in a cell-specific manner. Conversely, axo-
glial signaling pathways and myelin-associated proteins that
share the same spatial domains can modulate CAM actions.
Together, the advantages and disadvantages of CAMs, prompt
a nuanced approach in their use for combinatorial therapies
targeting myelination and axon regeneration.
Chondroitin Sulfate Proteoglycans
(CSPGs)
CSPGs constitute one of the important extrinsic factors limiting
CNS axon regeneration following injury (Davies et al., 1997;
Silver and Miller, 2004). OPCs, astrocytes and macrophages
account for the predominant expression of CSPGs, which
following SCI undergo tremendous modulation (Jones et al.,
2002). CSPGs on the cell surface are often released from the
membrane and become a part of the extracellular matrix (Carulli
et al., 2005). The majority of CSPGs present in the CNS
belong to the lectican family. Aggrecan, versican, neurocan,
brevican, phosphacan, neuroglycan-D, NG2 and phosphacan
constitute predominant CSPGs of the CNS (Carulli et al.,
2005). Aggrecan is expressed primarily by neurons, versican by
astrocytes, NG2 by OPCs and macrophages whereas neurocan
and brevican are expressed by all neural cells (neurons,
astrocytes and OPCs; Jones et al., 2002; Dyck and Karimi-
Abdolrezaee, 2015). Structurally, CSPGs contain a protein
core and glycosaminoglycan (GAG) side chains that routinely
undergo excessive branching or modifications like sulfation
(Carulli et al., 2005). Modifying the GAG chain lengths
(using enzyme Cha’se ABC) or their sulfation modulates CSPG
permissiveness for axon regeneration (Zuo et al., 1998; Wang
et al., 2008).
CSPGs interact with a multitude of axonal and growth
cone surface receptors such as Nogo receptor 1 (NgR1),
Nogo receptor 2 (NgR2), leukocyte common antigen (LAR)
and protein tyrosine phosphase σ (PTPσ). Possibly with
more players (such as p75NTR), CSPG-receptor interaction
can negatively regulate axon regeneration by activating the
Rho/ROCK signaling pathway (Dergham et al., 2002; Monnier
et al., 2003). A recent study suggests that extracellular CSPGs,
by an as yet unknown mechanism, can regulate local intra-
axonal translation of RhoA, thus ensuring an enhancement
of Rho/ROCK signaling in the axon (Walker et al., 2012).
Interestingly, studies implicate NG2 (expressed on OPCs) to
be the predominant CSPG following dorsal hemisection SCI
(Plant et al., 2001; Jones et al., 2002). NG2-positive OPCs
surround corticospinal axons within the injury environment
after SCI (Jones et al., 2002). Based upon this interaction,
NG2 could then serve as an important reason for impaired
axon regeneration following injury. However, even though NG2
per se inhibits axon growth, both postnatal and adult NG2
expressing cells are growth permissive (Dou and Levine, 1994;
Ughrin et al., 2003; Yang et al., 2006; Busch et al., 2010).
This paradox could be due to the co-expression of axonal
growth permissive substrates (e.g., laminin and fibronectin)
on NG2 positive cells (Yang et al., 2006). In addition,
SCs have been shown to express CSPGs that are sensitive
to treatment with chondroitinase (Cha’se) ABC, and which
retard DRG axon growth (Kuffler et al., 2009). Together
these findings suggest that glial CSPGs, both membrane-
bound and ECM-associated, can interact with several membrane
receptors on the axon, growth cone and soma to modulate
the axon growth machinery. Whether membrane bound
CSPGs can activate distinct molecular pathways in axons
as compared to those associated with the ECM remains
unknown.
OPCs show an increase in PTP expression during their
differentiation (Ranjan and Hudson, 1996). CSPGs negatively
regulate OL process outgrowth and the OL myelination program
by interacting with PTPσ (Pendleton et al., 2013). In one
study, aggrecan, neurocan and NG2, all inhibited OL process
outgrowth, and downregulated MBP expression, and this
effect was reversed by Cha’se ABC (Pendleton et al., 2013).
In addition, a combination of CSPGs (neurocan, versican,
phosphacan and aggrecan) led to a stronger phenotype of OL
process inhibition and MBP expression in OLs (Siebert and
Osterhout, 2011). Treatment of OPCs with Cha’se ABC also
enhanced their spontaneous differentiation towards O4-positive
OLs (Karus et al., 2016). This effect of Cha’se ABC could
be mediated by its ability to eliminate phosphacan/RPTPβ/ζ
from the OPC surface (Karus et al., 2016). Moreover, Cha’se
ABC stimulated neural precursor cells in the mouse spinal
cord to differentiate into OLs in large numbers (Karus et al.,
2016). Intracellularly, CSPG-mediated changes in the outgrowth
and alterations in the myelination program of OPCs and
OLs was mediated by PTPσ driven Rho/ROCK activation
(Pendleton et al., 2013). Together these findings suggest
that similar molecular pathways activate CSPG-mediated axon
growth inhibition and the OL myelination program. Therefore,
it is important that signaling intermediaries/downstream of
Rho/ROCK are identified so as to permit future therapeutic
targeting of CSPGs’ differential effects on myelination and axon
regeneration.
THE PHYSICAL PROPERTIES OF AXONS
AND THE CONGRUENCE OF
MYELINATION AND AXONAL GROWTH
Axonal Caliber and Radial Growth of Axons
Axon diameters vary in the CNS (0.1–24 µm), and accordingly,
their cross sectional area and volume (Barazany et al., 2009;
Perge et al., 2012). In an elegant experiment, Voyvodic showed
that altering the target size of postganglionic, unmyelinated
sympathetic axons altered their caliber, as well as the responses
of SCs towards them, suggesting a strong correlation between
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axonal caliber and myelination (Voyvodic, 1989). As a corollary
to Voyvodic’s (1989) work, axons that differ in their caliber
above the physiological limit (100 nm) appear to reflect the
information they carry to and from their target (Faisal et al.,
2005; Perge et al., 2012). In the PNS, axons less than 700
nm in diameter are not myelinated but are ensheathed by
a SC, or reside in a Remak bundle (Garbay et al., 2000).
Such a threshold for ensheathment and myelination is much
lower in the CNS, where OLs myelinate axons of around
200 nm diameter and axon-like nano fibers of ≥ 400 nm
in diameter in vitro (Waxman and Bennett, 1972; Lee et al.,
2013). OLs have been observed to produce myelin components
without the presence of axons, but intriguingly, in in vitro co-
cultures with neurons, OLs myelinate only axons even when
the dendrite diameters vary from 200 to 8000 nm, suggesting
a role for axon-specific signals in myelination (Ulfhake and
Cullheim, 1981; Dubois-Dalcq et al., 1986; Claiborne et al.,
1990; Lubetzki et al., 1993). Indeed, SCs that do not myelinate
cervical sympathetic axons were observed to myelinate sural
nerve axons, which routinely undergo myelination, reiterating
axon-specific signals for myelination (Aguayo et al., 1976).
Intriguingly, a linear relation between the cross-sectional area of
the myelin sheath and axon diameter (see G-ratio) was observed,
suggesting a role for the axonal surface in regulating myelin
sheath volume (Berthold et al., 1983; Paus and Toro, 2009). G-
ratio is the ratio of axonal diameter to fiber diameter (including
myelin sheath), used as a measure for optimal myelination.
An axon can influence its myelination by communicating
its information load via specific molecular signals to their
ensheathing cells (Fraher and Dockery, 1998). Supporting this
view, in the PNS, axons directly control the thickness of their
myelin sheath via the regulation of the expression of NRG1 type
III on the axonal membrane (Michailov et al., 2004; Taveggia
et al., 2008).
Conversely, myelination can affect axonal caliber in the
PNS and the CNS, effectively modulating their radial growth.
Myelinated axons have been consistently observed to have
a larger diameter than unmyelinated axons (Duncan, 1934;
Matthews and Duncan, 1971; Hoffman et al., 1984; de Waegh
et al., 1992). Myelination increases the cross sectional area
of the myelinated axonal segment up to 45% more than the
unmyelinated segment of the same axon (Monsma et al.,
2014). Structurally, medium and heavy neurofilaments (NF-
M and NF-H) principally determine the caliber of the axon,
and a defective NF phenotype presents with abnormal axonal
caliber (Hoffman et al., 1987; Cleveland et al., 1991; Muma
and Cork, 1993). Therefore, NF-M and NF-H could be among
the putative molecules responding to glial-derived, radial axon
growth signals. In SC-DRG co-culture experiments, myelinated
axonal segments were observed to contain nearly 42% more
NF-M as compared to unmyelinated segments of the same axon
(Monsma et al., 2014). SC-DRG co-culture experiments have
suggested that the factor responsible for an enlarged diameter
of myelinated axons was not secreted but rather a cell-to-cell
contact molecule (Windebank et al., 1985). So far, myelin-
associated molecules such as MAG, PLP, PMP22, MBP, and
sulfated and non-sulfated galactolipids (sulfatide/GalC) have
been suggested to play a role in axon-glial communication and
adhesion, to modulate the radial growth of axons (de Waegh
and Brady, 1990; Smith et al., 2013). MAG is a component
of non-compact PNS myelin in the periaxonal membrane
(Trapp and Quarles, 1984; Patzig et al., 2011). Mice having
a complete absence of MAG, and rats having a mutation
in MBP [LES (long Evans shaker)], show: (1) decreased NF
density in sciatic nerve axons; (2) decreased NF phosphorylation;
(3) decreased axonal caliber and, (4) progressive axonal loss
by Wallerian degeneration (Yin et al., 1998; Smith et al.,
2013). Addition of soluble MAG-Fc to DRG neuronal cultures
was found to increase the phosphorylation of NF-H, and
negatively regulate axonal degeneration induced by vincristine,
thus supporting the role of MAG in modulating axonal caliber
(Nguyen et al., 2009). However, so far very few studies
have addressed the mechanistic pathway connecting MAG
or other myelin-associated proteins to the radial growth of
axons. Growth cone collapse and the mechanisms thereof have
received a higher emphasis to date. MAG and OMgp also
cause longitudinal growth inhibition of axons by synergizing
with another MAI, Nogo-A, which binds to NgR1 to bring
about growth cone collapse (Cafferty et al., 2010). Lipid-
sulfatides are a novel class of MAIs that presumably work
through the canonical MAI pathway leading to growth cone
collapse in a Rho/ROCK dependent manner (Winzeler et al.,
2011).
Unraveling the mechanisms involved in the post-translational
modulation of NFs from glial derived signals remains an ongoing
pursuit. Initial thinking was that in the myelinated segments
of axons, heavily phosphorylated NF tail domain KSP motifs
exert repulsive forces on neighboring NFs by long side-arms and
hence spread apart. Whereas, in unmyelinated segments they
are less phosphorylated and therefore tightly packed (Hisanaga
and Hirokawa, 1988; Mukhopadhyay et al., 2004; Sihag et al.,
2007). Previous work has unequivocally shown that the
phosphorylation of NFs not only promotes NF-NF interactions,
but also affects their ability to associate with molecular motors
such as kinesin, dynein and myosinV (Yabe et al., 2000; Xia et al.,
2003; Motil et al., 2006; Kushkuley et al., 2009). On the contrary,
experiments conducted with a substitution of serine in the
KSP motifs of NF-M with phosphorylation-incompetent amino
acids demonstrated radial axonal growth to be independent
of the NF-M-KSP phosphorylation motif, but dependent on
the C terminal region of NF-M, thus prompting a relook at
the prevailing model of radial axonal growth (Garcia et al.,
2009). Recent evidence suggests that the C-terminal domains
of NF-M and NF-H can play a role in the stabilization of NFs
by modulating its proteolysis (Rao et al., 2012). Unmyelinated
peripheral axons do express components of all three different
forms of the proteolytic machinery (ubiquitin-proteasome
system, lysosomes and autophagy), which can be regulated by
neurotrophins (e.g., NGF; Frampton et al., 2012). Taken together,
post-translational modification of NFs seems to play a significant
role in modulating axonal caliber. However, mechanistic details
of how MAG, or any other myelin-associated molecule, can
modulate axonal caliber remains largely speculative. GSK3α/β,
CDK5, MAPK, SAPK/JNK, CKI/II are some of the implicated
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phosphokinases that can phosphorylate NFs, whereas PP1, PP2A
and PTP1B are some of the phosphatases known to reverse
NF phosphorylation (Shea et al., 2004; Snider and Omary,
2014). The proposed hypothesis is that MAG phosphorylates
NFs by interacting with the low affinity neurotrophin receptor
(p75NTR) to activate Raf/MEKK1/2/ERK1/2 via NRAGE.
In addition, p75NTR/NRAGE can inhibit PKA, leading to
increased Rho and inactivation of p35/Cdk5. This could
produce the decreased Cdk5 phosphorylation of NF as
well as decreased Cdk5-mediated inhibition of ERK1/2. The
signaling from MAG/p75NTR/NRAGE could then fine-tune the
phosphorylation status of NF-M and NF-H (Garcia et al., 2003).
However, unequivocal confirmation that MAG can recruit
these signaling pathways remains to be shown. Recently, in a
work identifying new players connected to NF phosphorylation,
a study found that the loss of β1 integrin could lead to the
phosphorylation of Tau at Ser262 (Lei et al., 2012). In a
separate study, MARK4/3 (microtubule-associated regulating
kinase) expression correlated with pTau (Ser262) levels in
granulovacuolar degeneration bodies of the Alzheimer’s diseased
brain, which shows progressive defects in NF phosphorylation
(Lund et al., 2014). Whether myelin-associated proteins could
mediate trans-regulation of the axonal proteolytic system
remains to be explored.
In summary, post-translational modifications of NF may
have differential effects on its stability and its association with
other NF molecules as well as transport motors, depending
on the specific kinase/phosphatase/proteolytic machinery within
the local environment. Specific glial and myelin-associated
molecules that regulate axonal caliber and their partners, along
with the related signaling network upon the axonal membrane,
are a significant gap in our understanding of axon-glial signaling
that needs further attention.
Myelination and Axonal Transport
The trembler mouse, which displays hypomyelination in the
PNS, also shows an altered axonal transport (de Waegh and
Brady, 1990). The trembler mouse has a point mutation in
PMP22 that encodes a peripheral-myelin enriched protein (Suter
et al., 1992). Decreased myelination of the sciatic nerve in the
trembler mouse was associated with increased NF transport
(1.73 mm/d in trembler vs. 1.56 mm/d in control; de Waegh
and Brady, 1990). In contrast, a slower NF transport velocity of
0.16 mm/d occurred in DRG neuron axonal segments that were
SC-myelinated, compared to 0.22 mm/day in the unmyelinated
segments (Monsma et al., 2014). It is interesting to note that the
NF transport rate has been reported to be quite heterogeneous,
depending on the cell type and the analysis method employed
(Shea and Chan, 2008). There is a considerable debate on the
role of phosphorylation of the NF tail domain in restricting NF
transport, since the evidence so far supports the role of NFs in the
radial growth of axons (Yuan et al., 2006; Sihag et al., 2007; Shea
and Chan, 2008).
Interestingly, addition of soluble MAG to the axonal
compartment of rat cortical cultures promoted the accumulation
of detyrosinated tubulin, and decreased tyrosinated tubulin
in a NgR-independent, but GalNAc-T dependent manner
(Nguyen et al., 2009). Though exciting, this finding needs
to be reconfirmed since the antibody used by Nguyen et al.
(2009) to detect de-tyrosinated tubulin (Chemicon: AB3210)
was raised against β-tubulin and the antibody used to detect
tyrosinated tubulin (Sigma: T9028) was raised against α-tubulin.
Post-translational modification of tubulin-dimers (typically
α-tubulin) by the addition or deletion of tyrosine is known to
regulate its association with kinesins andmany plus-end tracking
proteins (+TIPS), including p150Glued, a member of dynein-
dynactin retrograde motor complex, and CLIP-170, a CAP-
Gly domain-containing protein implicated in injury signaling
(Lomakin et al., 2009; Lloyd et al., 2012; Gumy et al., 2013; Prota
et al., 2013; Schneider et al., 2015). In addition, other players
can also be involved in modulating the axonal cytoskeleton.
Work has pointed towards notch signaling involvement in the
stabilization of microtubules through transcriptional regulation
of the microtubule severing protein, spastin (Ferrari-Toninelli
et al., 2008). Thus, post-translational modulation of axonal
tubulin by OL/SC surface molecules opens a completely new
chapter in glia-modulated structural and functional aspects of the
axonal cytoskeleton.
The precise signaling mechanisms involved in the regulation
of tubulin tyrosination remain unknown. Post-translationally
(phosphorylation) controlled tubulin tyrosine ligase (TTL)
activity regulates tubulin tyrosination (Idriss, 2000). Loss of
TTL leads to severe defects in microtubule-dependent retrograde
transport, specifically after axonal injury (Idriss, 2000; Song
et al., 2015). Mechanistic details of TTL phosphorylation remain
elusive, but MKP-1 can be one such putative candidate. A
novel MKP-1 (Map Kinase Phosphatase-1; MKP-1ASA) was
constructed by Jeanneteau et al. (2010) by mutating its RRR
motif in the MAPK binding domain, which eliminated the
binding of MKP-1 to ERK1/2 and p38 MAPK, but selectively
retained the MKP-1/JNK-1 interaction (Jeanneteau et al., 2010).
Ectopic expression of MKP-1ASA in the postnatal rat cortex
decreased JNK-1 activity and increased tyrosinated-α-tubulin
in both excitatory neurons and interneurons (Jeanneteau et al.,
2010). Moreover, different isoforms of JNK along with their
substrates, stathmins (e.g., SCG10, SCLIP), are known to be
crucial for microtubule stability and axon growth (Tararuk
et al., 2006; Barnat et al., 2010). Whether myelin-associated
proteins selectively trans-activate the MKP-1/JNK pathway to
regulate axonal TTL is an open question. A study suggested that
retrogradely transported TrkB-pERK could regulate the transient
expression of inducible MKP-1 (Jeanneteau et al., 2010). It
is therefore tempting to speculate that regeneration-associated
signaling and myelination could mutually influence each other
through cytoskeletal components. Elucidating these mechanisms
could provide novel avenues for regeneration research.
Adaptive Myelination
Neuronal activity influences oligodendrogenesis, OL
differentiation, myelination, and myelin thickness (Gyllensten
and Malmfors, 1963; Tauber et al., 1980; Barres and Raff,
1993; Stevens et al., 1998; Gibson et al., 2014). Decreasing the
neuronal activity just prior to developmental myelination of the
optic nerve, with the application of a sodium channel blocker
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(tetrodotoxin), has been shown to produce a 60% decrease in
the optic nerve myelination without affecting OPC numbers
(Demerens et al., 1996). In contrast, exposure of developing
zebrafish to the GABA antagonist pentylenetetrazole (PTZ),
in the bathing medium, not only increased neuronal activity,
but also led to a 40% increase in the number of myelin sheaths
made by OLs upon reticulospinal axons of the ventral spinal
cord, without any major changes in OL numbers (Mensch et al.,
2015).
Emerging evidence suggests that OLs can sense neuronal
activity and make decisions regarding the ensheathment of
axons (Hines et al., 2015). In a study involving spinal cord
samples of zebrafish embryos, individual OLs were seen
to lay the myelin sheath within 5 h of contact with the
target axons that were electrically active (Czopka et al.,
2013). Blocking sodium channels in zebrafish using TTX,
biased the stabilization, extension and maintenance of myelin
sheaths away from highly active axons, without affecting OL
differentiation. Further experiments highlighted that vesicle-
associated membrane protein (VAMP2) dependent extra-
synaptic axonal secretion regulated the maintenance of OL
ensheathment (Wake et al., 2011; Hines et al., 2015). Inhibition
of synaptic vesicle release in developing zebrafish could reduce
the average number of myelin sheaths for OLs by 30%, OL
numbers by 10% and the number of myelinated reticulospinal
axons by 40% (Mensch et al., 2015). Optogenetic stimulation of
the premotor cortex (M2) in a transgenic mice (heterozygous
for Thy1::ChR2) led to similar findings of activity-dependent
myelination with functional modulation (Gibson et al., 2014).
Extrasynaptic neurotransmitter release from neurons is
known to modulate purinergic and glutamatergic signaling in
glia (Stevens et al., 2002; Kukley et al., 2007; Ziskin et al., 2007;
Thyssen et al., 2010; Wake et al., 2011). Extrasynaptic glutamate
release from DRG neuronal cultures is vesicular, whereas ATP
release appears to be non-vesicular (Wake et al., 2011). Sensory
neuronal activity activates the PI3K/Akt/CREB pathway in
SCs by an ATP-dependent mechanism, possibly involving P2Y
purinergic receptors, which results in an inhibition of the
proliferation and differentiation of SCs (Stevens and Fields,
2000). On the contrary, priming by adenosine, not ATP,
promotes OPC differentiation and subsequent myelination
of DRG in co-culture studies (Stevens et al., 2002). The
pro-myelinating features of purinergic signaling have been
found to operate predominantly through the OPC somata,
which is not in direct contact with the axon underneath
(Wake et al., 2011). Previous studies with neuron-OPC co-
cultures hinted towards the existence of soluble signals from
neurons that could affect the way OPCs regulate myelin
biogenesis (Simons and Trajkovic, 2006). This work found that
neuronal signals reversed the cholesterol-dependent endocytosis
within OPCs and triggered the fusion of PLP/DM20 (compact
intermodal myelin proteins) carrying late endosomes/lysosomes
(Simons and Trajkovic, 2006). DRG:OPC co-culture studies
revealed that glutamate release from axons forms the main hub
for axon-glial signaling through its interaction withmetabrotopic
(mGluR) and ionotropic (NMDR) glutamate receptors on the
OPC processes (Wake et al., 2011). More recent studies have
highlighted the role that AMPA/Kainate glutamate receptors
play in regulating OPC response to vesicular glutamate release
from axons/de novo synapses (Fannon et al., 2015; Gautier
et al., 2015). In DRG:OPC co-cultures, electrical stimulation of
neurons produced an increased clustering of phosphorylated
Fyn kinase at cholesterol-rich micro domains on OPCs, as
visualized by the transferrin receptor (TfR; Wake et al.,
2011). Phosphorylated Fyn kinase has been reported to, in
turn, phosphorylate heterogeneous nuclear ribonucleoprotein
A2 (hnRNPA2), which is located within the OPC processes.
Fyn phosphorylation of hnRNPA2 releases the repression on
MBP mRNA, making it available for local translation (White
et al., 2008). Indeed, neuronal activity enhances the local
translation of MBP in the OPC processes (Wake et al.,
2011).
There is emerging evidence that the activity-dependent
regulation of OPC programming and their subsequent ability
to myelinate axons might have many more players than
previously thought. Intriguingly, in DRG-OPC co-cultures,
NRG (NRG1β, soluble) and BDNF were able to switch the OPC
myelination program from activity-independent to activity-
dependent (Lundgaard et al., 2013). N-methyl-D-aspartate
receptors (NMDA) on OPCs mediate NRG-induced OPC
maturation and myelination (Lundgaard et al., 2013). The
activity-dependent myelination program in OPCs, in the
presence of NRG, was inhibited by an antibody that blocked
β1 integrin (Lundgaard et al., 2013). Additionally, sodium-
dependent glutamate transporters (excitatory amino acid
transporters, EAAT1/2/3) can mediate glutamate signaling via
CaMKIIβ, to modulate OPC morphology and myelin biogenesis
(Martinez-Lozada et al., 2014). This highlights that adaptive
myelination could be further subjected to cis-regulation on
myelinating glia.
Studies have also suggested that activity-dependent axon-
glial/neuron-glial communication could be mutual. Neuronal
activity can promote Rab35-mediated exosome release from
OPCs, in an AMPA/NMDA-dependent manner. Neurons
internalize these exosomes by taking them up via axonal and
somatodendritic compartments (Fruhbeis et al., 2013). The
exosomes contain myelin component proteins (e.g., PLP) and
heat shock proteins, which provide ER and starvation protection
to neurons. Neuronal activity has also been identified to directly
regulate axonal growth by modulating GAP-43 transcription and
post-translational regulation, in addition to altering key signaling
pathways (e.g., Notch) that might have a profound impact on
regeneration and neuropathic pain post-injury (Cantallops and
Routtenberg, 1999; Howe, 2003; Alberi et al., 2011). Neuronal
activity regulates neuronal notch signaling in an Arc/Arg3.1-
dependent manner (Sestan et al., 1999; Alberi et al., 2011).
In adult NG2+ OPCs, neuronal activity was also reported to
promote ADAM10 dependent cleavage of NG2, one of the
extrinsic inhibitory factors for axonal regeneration post-injury
(Dou and Levine, 1994; Ughrin et al., 2003; Sakry et al., 2014).
Taken together, these findings suggest that axon-glia
communication is dynamic, offering a potential untapped
target for remyelination therapeutics. The molecular machinery
in adaptive myelination includes those responding to both
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paracrine (NRG1 and neurotransmitter) as well as local signaling
(β1 integrins). Further experiments to understand the precise
molecular nodes required for the provision of an on-demand
stimulation of themyelination program remain to be undertaken.
SUMMARY
Nervous system injury, such as trauma to the spinal cord,
poses a challenge to the intricately laid myelin structure
surrounding axons. The loss of the myelinating glia or myelin
damage leads to eventual myelin degradation and denuding of
the axon, then axonal retraction of cut axons or conduction
block within those spared, but demyelinated axons (Olby
and Blakemore, 1996; Grossman et al., 2001; Guest et al.,
2005; Hagg and Oudega, 2006; Lytle and Wrathall, 2007; Ek
et al., 2012; Seidl, 2014). Axon-glial communications during
the myelination process affect two critical decisions in axonal
growth. The first of these are the signals for ensheathment and
myelination of the axon that originate in axons themselves,
while the second are signals that inhibit longitudinal growth
to promote radial growth of the axon that originate from
glia. Studies have highlighted the importance of PI3K/Akt
in the myelination program and ERK/p38MAPK in axonal
growth. However, accumulating evidence also suggests that
outcomes of Akt/MAPK signaling cascades can be tremendously
influenced by various cis and trans regulators on axon-
glial surfaces, myelin components and co-activated signaling
pathways. In addition, neuronal activity regulates the nature
of axon-glial communication. Multiple molecules, canonically
known to be important for myelination and axonal growth
(e.g., notch, NRG, integrins and L1-CAM etc.) respond actively
to neuronal activity. On certain occasions, surface ligands
themselves can alter the downstream canonical signaling.
In summary, various axon-glial communications regulate the
myelination program and axonal cytoskeleton, by modulating
the critical nodes of intracellular signaling pathways and the
neuron-glia transcriptional network. This highlights a need for
combinatory approaches that modulate both surface axon-glial
communication and intracellular signaling to effectively control
the process of axon growth and myelination.
There is an enormous need to revisit axon-glial signaling
in clinically relevant nervous system injury models to generate
an index of perturbed pathway components and axon-glial
surface molecules. Specifically, a comprehensive understanding
of the signaling pathways that are mediated through myelin
components, both intact and debris, in the regulation of radial
axon growth is needed. Further investigation into how these
signals intersect with those pathways implicated in the initiation
and elongation of axons during longitudinal growth, may offer
unique opportunities for targeting the temporal regulation
of endogenous and exogenous (implanted) glia interactions,
as well as their communication with the injured axon to
maximize axon growth to appropriate targets. Given the amount
of glial cells the regenerating axons encounter in an injury
scenario, it would therefore be appropriate to negatively target
glial-derived axon growth inhibitory signals, and positively
amplify longitudinal axon growth promoting signals for effective
regeneration. Understanding this critical network holds the key
to prime selectively the myelination program or to promote
axonal growth.
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